GMF-β depletion affects the β-elemene antiproliferative effects in vitro hampering MKK3 activation [38], uncovering a novel molecular mechanism involving MKK3 and GMF-β in the β-elemene driven inhibition of glioblastoma cell proliferation. The gene discussed is MAP2K3; the disease is glioblastoma.